Rheumatic Heart Disease Market to Reach $3.42 Billion by 2029, Growing at a CAGR of 5.9%

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Rheumatic Heart Disease Industry In 2025?

The market for rheumatic heart disease has experienced robust growth in recent years. This market is expected to expand from $2.56 billion in 2024 to $2.71 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.9%. Historically, this expansion has been driven by factors such as the widespread existence of untreated strep infections, restricted healthcare access in lower-income areas, insufficient public understanding of rheumatic heart disease, delays in diagnosis and treatment, and inadequate immunization initiatives.

The rheumatic heart disease market is anticipated to demonstrate robust growth in the coming years, with its size projected to reach $3.42 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.9%. This expansion during the forecast period is attributable to an increased uptake of preventive screening programs, rising awareness concerning early detection, greater healthcare investments in developing areas, the broadening reach of telemedicine for remote diagnosis, and governmental efforts aimed at disease prevention. Significant trends expected during this period include the escalating integration of AI into diagnostics, the wider implementation of echocardiography-based screening, the incorporation of mobile health solutions, the development of new anti-inflammatory therapies, and collaborative initiatives for global disease eradication.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23502&type=smp

Which Drivers Are Supporting Growth Of The Rheumatic Heart Disease Market?

The expanding occurrence of strep throat is anticipated to fuel the expansion of the rheumatic heart disease market in the future. Strep throat is defined as a bacterial infection stemming from streptococcus pyogenes (group a streptococcus), resulting in throat inflammation and discomfort, frequently alongside fever, enlarged lymph nodes, and swallowing difficulties. A surge in antibiotic resistance is complicating the effective treatment of streptococcal infections, contributing to extended illnesses and elevated transmission rates within communities. Rheumatic heart disease emerges as a chronic consequence of strep throat infections that are either untreated or recurring, emphasizing the criticality of prompt diagnosis and intervention for streptococcal infections to avert serious cardiac impairment. As an illustration, in April 2023, the Centers for Disease Control and Prevention, a US-based government department, reported that strep throat is responsible for approximately 5.2 million annual outpatient visits among individuals under 65 years old. These consultations result in 2.8 million antibiotic prescriptions annually. Consequently, the growing prevalence of strep throat is propelling the development of the rheumatic heart disease market.

How Is The Rheumatic Heart Disease Market Classified Into Different Segments?

The rheumatic heart diseasemarket covered in this report is segmented –

1) By Type: Valve; Myocarditis; Pericarditis

2) By Age Group: Pediatric; Adolescent; Adult; Geriatric

3) By Application: Hospital; Diagnostic Centre; Research Centre

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Direct Sales

Subsegments:

1) By Valve: Mitral Valve Disease; Aortic Valve Disease; Tricuspid Valve Disease; Pulmonary Valve Disease

2) By Myocarditis: Acute Myocarditis; Chronic Myocarditis; Fulminant Myocarditis

3) By Pericarditis: Acute Pericarditis; Chronic Pericarditis; Constrictive Pericarditis; Effusive Pericarditis

What Are The Major Trends Driving The Growth Of The Rheumatic Heart Disease Market?

Leading entities within the rheumatic heart disease market are embracing strategic collaborations to advance the creation of novel treatments and diagnostic methods. These alliances for rheumatic heart disease (RHD) management bring together various resources and specialized knowledge, facilitating progress in research and development, refining diagnostic and therapeutic breakthroughs, broadening market access, and accelerating product commercialization. A notable instance occurred in July 2023, when the World Heart Federation (WHF), a non-governmental organization headquartered in Switzerland, entered into a partnership with the Philips Foundation, a nonprofit organization based in the Netherlands. Their objective was to heighten awareness, enhance medical education, and bolster early detection of rheumatic heart disease (RHD) across the Asia-Pacific (APAC) region. Initiated in the Philippines, this program aims to improve healthcare accessibility for more than half a million Filipino children at risk, achieved by furnishing medical facilities with skilled personnel and sophisticated diagnostic instruments. This particular cooperative effort emphasizes a shared dedication to reinforcing healthcare systems and guaranteeing prompt treatment for individuals affected by RHD.

Who Are The Major Companies Operating In The Rheumatic Heart Disease Market?

Major companies operating in the rheumatic heart disease market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, Abbott Laboratories, GlaxoSmithKline plc (GSK), Medtronic plc, Siemens Healthineers AG, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., Mayo Clinic, Boston Scientific Corporation, Johns Hopkins Medicine, Terumo Corporation, The Mount Sinai Health System Inc., Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, Medanta.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/rheumatic-heart-disease-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Rheumatic Heart Disease Market?

North America was the largest region in the rheumatic heart disease market in 2024. The regions covered in the rheumatic heart disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Rheumatic Heart Disease Market Report:

https://www.thebusinessresearchcompany.com/customise?id=23502&type=smp

Browse Through More Reports Similar to the Global Rheumatic Heart Disease Market 2025, By The Business Research Company

Prosthetic Heart Valve Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prosthetic-heart-valve-devices-and-equipment-global-market-report

Hearth Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hearth-global-market-report

Flea Tick And Heartworm Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/flea-tick-and-heartworm-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795